Aurobindo Pharma Limited, Unit I is an API manufacturer based in India. Its GMP standing is certified by EMA.
| Site | FDA FEI |
|---|---|
| Borpatla Village, India | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Amisulpride | SFDA (Saudi Arabia) | 1 |
| Atorvastatin | SFDA (Saudi Arabia) | 1 |
| Bisoprolol | SFDA (Saudi Arabia) | 1 |
| Cefdinir | SFDA (Saudi Arabia) | 1 |
| Cefuroxime Axetil | SFDA (Saudi Arabia) | 1 |
| Entacapone | SFDA (Saudi Arabia) | 1 |
| Metformin | SFDA (Saudi Arabia) | 1 |
| Metoprolol | SFDA (Saudi Arabia) | 1 |
| Ondansetron | SFDA (Saudi Arabia) | 1 |
| Pantoprazole | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| EMA | None | 1 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Ask Fred what the record holds on Aurobindo Pharma Limited, Unit I, including filings and inspection history.
Chat with Fred, your AI analystRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.